WASHINGTON, April 17, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced it will release its first quarter 2023 financial results on Wednesday, May 3, 2023, after market close, with a conference call to follow at 5 p.m. ET.
Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 855.940.9467 or 412.317.6034 for international callers and referencing the "Evolent Health call" 15 minutes prior to the call. An audio playback of the conference call will be available on Evolent's investor relations website, ir.evolenthealth.com, for 90 days after the call.
Investor Day
In addition, Chief Executive Officer and Co-Founder Seth Blackley and Evolent's executive team will host an Investor Day for the financial community via webcast and in person in Arlington, Va. on Tuesday, May 23, 2023.
The event will feature presentations from Evolent's executive leadership team on the company's long-term corporate strategy, innovative value-based care solutions, and financial outlook. Management will also host a Q&A session with attendees.
A live audio and visual webcast of this event, along with supporting materials, will be available the day of the event on Evolent's investor relations website at ir.evolenthealth.com/. A replay, presentations and transcript will also be available after the event. An audio playback of the event will be available on Evolent's investor relations website, ir.evolenthealth.com, for 90 days after the call.
The event will be held at the Westin in Arlington Tuesday, May 23, 2023, at 10 a.m. ET and is anticipated to end at approximately 1 p.m. ET.
About Evolent Health
Evolent Health delivers proven solutions that improve outcomes while making health care simpler and more affordable. We specialize in better health outcomes for people with complex conditions. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolenthealth.com.
Contacts:
Seth R. Frank
Vice President, Investor Relations
Evolent Health, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.
571-895-3919 (W)
Last Trade: | US$12.54 |
Daily Change: | -0.06 -0.48 |
Daily Volume: | 1,849,438 |
Market Cap: | US$1.440B |
November 07, 2024 November 07, 2024 August 08, 2024 June 04, 2024 May 09, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load